Skip to Content

International Journal of Neonatal Screening, Volume 8, Issue 4

2022 December - 17 articles

Cover Story: Each year almost 4 million newborns are screened for treatable conditions using both physiological and blood-based methods. Expansion of newborn screening (NBS) to include more conditions is usually triggered by the development of novel technologies to screen, diagnose, and/or treat disease. Discoveries of interventions for Duchenne Muscular Dystrophy (DMD) have led to research to determine if early identification through NBS leads to improved health outcomes. This issue of IJNS features an innovative model of piloting NBS for DMD using a consortia approach led by an advocacy group partnering with a state NBS program, a foundation, and multiple birth hospitals. The first year of a two-year DMD pilot demonstrates a useful model of collaboration to establish an evidence base to advance NBS. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (17)

  • Article
  • Open Access
10 Citations
3,524 Views
11 Pages

A Retrospective Evaluation of the Predictive Value of Newborn Screening for Vitamin B12 Deficiency in Symptomatic Infants Below 1 Year of Age

  • Ulf Wike Ljungblad,
  • Morten Lindberg,
  • Erik A. Eklund,
  • Ingjerd Sæves and ,
  • Carlos Sagredo,
  • Anne-Lise Bjørke-Monsen and
  • Trine Tangeraas
  • + 2 authors+ 0 author

Background: The sensitivity of newborn screening (NBS) in detecting infants that later develop symptomatic vitamin B12 deficiency is unknown. We evaluated the predictive value using NBS algorithms in detecting infants that later were clinically diagn...

  • Article
  • Open Access
4 Citations
4,029 Views
10 Pages

Congenital Cytomegalovirus Screening in Massachusetts Birth Hospitals: A Statewide Survey

  • Cheryl K. Glovsky,
  • Kendall Carroll,
  • Naomi Clark,
  • Peter Colleran and ,
  • Vanessa Colleran,
  • Shayne Gaffney,
  • Margaret Kenna,
  • Evelyn Kuhns-Rankin,
  • Tracy Evans Luiselli and
  • Michael S. Cohen
  • + 10 authors+ 5 authors

This study sought to assess the current state of screening for congenital cytomegalovirus infection in newborns among birth hospitals and newborn nurseries in the state of Massachusetts. A survey assessing hospital protocols for cytomegalovirus testi...

(This article belongs to the Special Issue Newborn Screening for Congenital CMV)
  • Article
  • Open Access
2 Citations
3,703 Views
7 Pages

Technical Study of Automated High-Throughput High-Sensitive Ceruloplasmin Assay on Dried Blood Spots—Reinstate the Potential Use for Newborn Screening of Wilson Disease

  • Chloe Miu Mak,
  • Ching Tung Choi,
  • Tsz Ki Wong,
  • Hanson Heearn Chin and ,
  • Hillman Kai Yin Lai and
  • Koon Yu Yuet
  • + 1 author+ 0 author

In this study, we modified a fully automatic immunoassay on ceruloplasmin concentration on dried blood spots (DBS) to increase its analytical sensitivity in order to accurately differentiate newborns from true Wilson disease (WD) patients. Modificati...

  • Article
  • Open Access
2 Citations
3,578 Views
15 Pages

Parents increasingly utilise the internet to obtain information on health practices, but the quality of online information about screening for inherited metabolic diseases (IMD) needs to be improved. A content analysis examined how IMD blood and urin...

  • Review
  • Open Access
47 Citations
11,662 Views
15 Pages

Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories

  • Michael H. Gelb,
  • Khaja Basheeruddin,
  • Alberto Burlina,
  • Hsiao-Jan Chen and ,
  • Yin-Hsiu Chien,
  • George Dizikes,
  • Christine Dorley,
  • Roberto Giugliani,
  • Amy Hietala and
  • Dietrich Matern
  • + 21 authors+ 16 authors

Tandem mass spectrometry (MS/MS) is the most universal platform currently available for the analysis of enzymatic activities and biomarkers in dried blood spots (DBS) for applications in newborn screening (NBS). Among the MS/MS applications in NBS, t...

(This article belongs to the Special Issue Tandem Mass Spectrometry in Newborn Screening)
  • Review
  • Open Access
10 Citations
4,297 Views
13 Pages

The mucopolysaccharidoses (MPS), Pompe Disease (PD), and Krabbe disease (KD) are inherited conditions known as lysosomal storage disorders (LSDs) The resulting enzyme deficiencies give rise to progressive symptoms. The United States Department of Hea...

  • Article
  • Open Access
16 Citations
3,408 Views
13 Pages

Newborn congenital cytomegalovirus (cCMV) screening programs have been found to increase the rates of early diagnosis and treatment. In North America, newborn cCMV screening programs have not been widely implemented, leaving healthcare providers to r...

(This article belongs to the Special Issue Newborn Screening for Congenital CMV)
  • Article
  • Open Access
17 Citations
4,151 Views
12 Pages

Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders

  • Natalie A. Boychuk,
  • Niamh S. Mulrooney,
  • Nicole R. Kelly,
  • Aaron J. Goldenberg and ,
  • Ellen J. Silver and
  • Melissa P. Wasserstein
  • + 1 author+ 0 author

The ability to screen newborns for a larger number of disorders, including many with variable phenotypes, is prompting debate regarding the psychosocial impact of expanded newborn bloodspot screening (NBS) on parents. This study compares psychologica...

(This article belongs to the Special Issue Psychosocial Impact of Positive Newborn Screening)
  • Article
  • Open Access
20 Citations
6,669 Views
18 Pages

Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors

  • Martin Kharrazi,
  • Charlene Sacramento,
  • Anne Marie Comeau,
  • Jaime E. Hale and ,
  • Michele Caggana,
  • Denise M. Kay,
  • Rachel Lee,
  • Brendan Reilly,
  • John D. Thompson and
  • Bradford L. Therrell
  • + 17 authors+ 12 authors

Testing immunoreactive trypsinogen (IRT) is the first step in cystic fibrosis (CF) newborn screening. While high IRT is associated with CF, some cases are missed. This survey aimed to find factors associated with missed CF cases due to IRT levels bel...

  • Article
  • Open Access
3 Citations
3,027 Views
6 Pages

To improve the positive predictive value (PPV) of newborn screening for 21-hydroxylase deficiency (21OHD), co-variates have been used to modify 17-hydroxyprogesterone (17OHP) cutoffs. The objective of this study is to evaluate whether 17OHP screening...

  • Article
  • Open Access
16 Citations
4,329 Views
11 Pages

Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand

  • Mark R. de Hora,
  • Natasha L. Heather,
  • Dianne R. Webster,
  • Benjamin B. Albert and
  • Paul L. Hofman

Between 2005 and 2021, 49 cases of classical congenital adrenal hyperplasia were diagnosed in New Zealand, 39 were detected in newborns and 10 were not detected by screening. Currently, for every case of CAH detected by screening, 10 false-positive t...

  • Editorial
  • Open Access
14 Citations
3,756 Views
3 Pages

It has recently been announced that the Secretary of the U.S. Department of Health and Human Services has approved the recommendation by the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) to add mucopolysaccharidosis type...

  • Article
  • Open Access
5 Citations
2,991 Views
14 Pages

Our objective was to develop and test a new approach to obtaining parental policy guidance about disclosure of incidental findings of newborn screening for cystic fibrosis (CF), including heterozygote carrier status and the conditions known as CFTR-r...

(This article belongs to the Special Issue Ethical and Psychosocial Aspects of Genomics in the Neonatal Period)
  • Review
  • Open Access
72 Citations
8,433 Views
30 Pages

Genomic advances have contributed to a proliferation of newborn screening (NBS) programs. Psychosocial consequences of NBS have been identified as risks to these public health initiatives. Following PRISMA guidelines, this systematic review synthesiz...

(This article belongs to the Special Issue Psychosocial Impact of Positive Newborn Screening)
  • Article
  • Open Access
4 Citations
4,487 Views
8 Pages

Changes in the Incidence of Infantile Spinal Muscular Atrophy in Shikoku, Japan between 2011 and 2020

  • Kentaro Okamoto,
  • Hisahide Nishio,
  • Takahiro Motoki,
  • Toshihiro Jogamoto and ,
  • Kaori Aibara,
  • Yoichi Kondo,
  • Kentaro Kawamura,
  • Yukihiko Konishi,
  • Chiho Tokorodani and
  • Mariko Eguchi
  • + 6 authors+ 1 author

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder. Al-though there was no cure for SMA, newly developed therapeutic drugs (nusinersen, onasemnogene abeparvovec, and risdiplam) have been proven effective for the improvemen...

(This article belongs to the Collection Newborn Screening in Japan)
  • Commentary
  • Open Access
33 Citations
7,760 Views
9 Pages

Newborn screening was established over 50 years ago to identify cases of disorders that were serious, urgent, and treatable, mirroring the criteria of Wilson and Jungner. In the last decade, conditions have been added to newborn screening that do not...

(This article belongs to the Special Issue Ethical and Psychosocial Aspects of Genomics in the Neonatal Period)
  • Article
  • Open Access
24 Citations
6,849 Views
15 Pages

Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot

  • Michael J. Hartnett,
  • Michele A. Lloyd-Puryear,
  • Norma P. Tavakoli,
  • Julia Wynn and ,
  • Carrie L. Koval-Burt,
  • Dorota Gruber,
  • Tracy Trotter,
  • Michele Caggana,
  • Wendy K. Chung and
  • Amy M. Brower
  • + 6 authors+ 1 author

Advancements in therapies for Duchenne muscular dystrophy (DMD) have made diagnosis within the newborn period a high priority. We undertook a consortia approach to advance DMD newborn screening in the United States. This manuscript describes the form...

XFacebookLinkedIn
Int. J. Neonatal Screen. - ISSN 2409-515X